Constructs of human neuropathy target esterase catalytic domain containing mutations related to motor neuron disease have altered enzymatic properties.
Neuropathy target esterase (NTE) is a phospholipase/lysophospholipase associated with organophosphorus (OP) compound-induced delayed neurotoxicity (OPIDN). Distal degeneration of motor axons occurs in both OPIDN and the hereditary spastic paraplegias (HSPs). Recently, mutations within the esterase domain of NTE were identified in patients with a novel type of HSP (SPG39) designated NTE-related motor neuron disease (NTE-MND). Two of these mutations, arginine 890 to histidine (R890H) and methionine 1012 to valine (M1012V), were created in human recombinant NTE catalytic domain (NEST) to measure possible changes in catalytic properties. These mutated enzymes had decreased specific activities for hydrolysis of the artificial substrate, phenyl valerate. In addition, the M1012V mutant exhibited a reduced bimolecular rate constant of inhibition (k(i)) for all three inhibitors tested: mipafox, diisopropylphosphorofluoridate, and chlorpyrifos oxon. Finally, while both mutated enzymes inhibited by OP compounds exhibited altered time-dependent loss of their ability to be reactivated by nucleophiles (aging), more pronounced effects were seen with the M1012V mutant. Taken together, the results from specific activity, inhibition, and aging experiments suggest that the mutations found in association with NTE-MND have functional correlates in altered enzymological properties of NTE.
Hein
Nichole D
ND
Department of Neurology, University of Michigan, Ann Arbor, MI 48109-2029, USA.
Stuckey
Jeanne A
JA
Rainier
Shirley R
SR
Fink
John K
JK
Richardson
Rudy J
RJ
D002265:Carboxylic Ester Hydrolases / Q000037:antagonists & inhibitors / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D020134:Catalytic Domain; D004390:Chlorpyrifos / Q000031:analogs & derivatives / Q000494:pharmacology; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006801:Humans; D006868:Hydrolysis; D007531:Isoflurophate / Q000031:analogs & derivatives / Q000494:pharmacology; D007700:Kinetics; D016472:Motor Neuron Disease / Q000201:enzymology* / Q000235:genetics; D016297:Mutagenesis, Site-Directed; D009154:Mutation; D011994:Recombinant Proteins / Q000378:metabolism; D015419:Spastic Paraplegia, Hereditary / Q000201:enzymology* / Q000235:genetics; D013379:Substrate Specificity; D014631:Valerates / Q000378:metabolism
D004791:Enzyme Inhibitors; D011994:Recombinant Proteins; D014631:Valerates; D007531:Isoflurophate; C049867:phenyl valerate; C005238:mipafox; C009618:O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate; D002265:Carboxylic Ester Hydrolases; C021859:neurotoxic esterase; D004390:Chlorpyrifos
Mol Cell Biol. 2004 Feb;24(4):1667-79
14749382
BMC Neurosci. 2005 Feb 01;6:6
15686598
Biochim Biophys Acta. 1981 Aug 13;660(2):306-16
7284405
Biochem J. 1998 May 15;332 ( Pt 1):1-4
9576844
Protein J. 2007 Apr;26(3):165-72
17216363
Toxicol Appl Pharmacol. 1999 Feb 15;155(1):43-53
10036217
J Theor Biol. 2002 Sep 21;218(2):207-14
12381293
Fundam Appl Toxicol. 1997 Jul;38(1):55-63
9268605
Biochem J. 2003 Jul 1;373(Pt 1):33-40
12665427
Fundam Appl Toxicol. 1986 Apr;6(3):464-71
3699331
Arch Toxicol. 1977 Jun 18;37(2):113-5
577680
Cell Cycle. 2008 May 1;7(9):1157-60
18418040
Biochem J. 1969 Oct;114(4):711-7
4310054
Toxicol Lett. 1987 Apr;36(2):197-204
3576651
Toxicol Lett. 1998 Mar 31;95(2):93-101
9635412
J Toxicol Environ Health A. 2003 Jun 27;66(12):1145-57
12791540
Toxicol Rev. 2005;24(1):37-49
16042503
J Neurosci. 2009 Sep 16;29(37):11594-600
19759306
Biochem J. 1979 Feb 1;177(2):549-58
435251
Anal Chem. 2007 Jul 15;79(14):5196-203
17555296
Arch Toxicol. 1978 Dec 28;41(3):215-21
736792
Ann Oncol. 2009 Aug;20 Suppl 6:vi35-40
19617296
J Biol Chem. 2000 Aug 11;275(32):24477-83
10816586
Proc Natl Acad Sci U S A. 2003 Jun 24;100(13):7983-7
12805562
Fundam Appl Toxicol. 1993 Apr;20(3):273-9
7684990
Fundam Appl Toxicol. 1996 Mar;30(1):23-30
8812209
Biochemistry. 2004 Mar 30;43(12):3716-22
15035642
Am J Pathol. 1979 Feb;94(2):241-52
426027
Proc Natl Acad Sci U S A. 2004 Apr 6;101(14):5075-80
15051870
Toxicol Appl Pharmacol. 2008 Nov 1;232(3):376-83
18706436
Am J Hum Genet. 2008 Mar;82(3):780-5
18313024
Arch Toxicol. 1991;65(2):150-5
1711837
Toxicol Lett. 2006 Mar 15;162(1):94-7
16309859
J Biol Chem. 2004 Jun 4;279(23):24024-33
15044461
J Anal Toxicol. 1991 Mar-Apr;15(2):86-9
2051750
J Biol Chem. 2002 Jun 7;277(23):20942-8
11927584
J Neurosci. 2005 Mar 16;25(11):2865-73
15772346